Kansas wins controversial biolab?

Manhattan, Kansas has been chosen as the site for the much-contested $450 million government biolab, which will house research on some of the most highly infectious human and animal pathogens, according to a draft document from the Department of Homeland Security leaked to the press. (Click linkurl:here;http://www2.ljworld.com/documents/2008/dec/03/nbaf-preferred-alternative-selection-memorandum/ for the document, posted by the Lawrence Journal World and News.) The decision on the prospectiv

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Manhattan, Kansas has been chosen as the site for the much-contested $450 million government biolab, which will house research on some of the most highly infectious human and animal pathogens, according to a draft document from the Department of Homeland Security leaked to the press. (Click linkurl:here;http://www2.ljworld.com/documents/2008/dec/03/nbaf-preferred-alternative-selection-memorandum/ for the document, posted by the Lawrence Journal World and News.) The decision on the prospective lab, called the National Bio and Agro-Defense Facility (NBAF), has yet to be finalized by federal officials -- a process which could take a month, the linkurl:Kansas City Star;http://www.kansascity.com/105/story/921286.html reports. However, other sites which have been competing for project -- including facilities in Athens, Ga.; Butner, NC.; Flora, Miss., and San Antonio, TX, -- may not take the news lying down. "Let me just simply say that we're looking at (a challenge) very seriously because we do think we have the best site and we'll proceed accordingly," Mississippi Gov. Haley Barbour told the linkurl:AP;http://www.google.com/hostednews/ap/article/ALeqM5jmf-rVYLzqr_0u37pjHZ0ceupbWgD94RQ5A81 Wednesday (December 3). Meanwhile, biosecurity experts continue to oppose NBAF, which was proposed in 2006 and will be the largest high-security biocontainment lab in the world, conducting research on pathogens such as foot and mouth disease (FMD), rift valley fever, and anthrax. Richard Ebright, a microbiologist at Rutgers University in New Jersey, summarized his response to the Kansas decision in an email to The Scientist as follows: "###Unsafe. (Foot-and-mouth-disease virus cannot safely be handled at a mainland location.) ###Unnecessary. (No scientific rationale. No scientific purpose. No scientific necessity.) ###A DHS planning failure on par with Katrina. ###Should be terminated by the Obama Administration or the new Congress." NBAF would also replace the aging lab on Plum Island in New York, an island facility off the tip of Long Island to which the country's research on FMD has been relegated since 1955. While Plum Island is a biosafety level (BSL)-3 facility, however, the new lab would be equipped to work on still more dangerous pathogens requiring the highest containment level, BSL-4. An assessment this summer by the Government Accountability Office questioned the safety of positioning such research on the mainland, and experts have noted that several of the proposed sites, including Kansas, are located close to the country's agricultural core, increasing the potential danger posed by a leak. **__Related stories:__** * linkurl: Mainland animal lab poses risks: GAO;http://www.the-scientist.com/blog/display/54670/ [22nd May 2008]* linkurl:Pathogen labs lack security: GAO;http://www.the-scientist.com/blog/display/55093/ [16th October 2008]* linkurl:US homeland security to build animal biolab;http://www.the-scientist.com/news/display/23091/ [6th February 2006]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Alla Katsnelson

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio 
Zymo Research

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences